These results, together with a prior report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 support the idea of concentrating on ACKR3 as a novel way to modulate the opioid method, which could open new therapeutic avenues for opioid-linked disorders. Study on conolidine is proscribed, https://hafizr034jda5.losblogos.com/26410009/rumored-buzz-on-conolidine